← SynDRA
DACTOLISIB
SynDRA canonical compound SYN0027972 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | PIK3CG |
| Mechanism of action | PI3K inhibitor |
All known targets
- MTOR
- PIK3CG
- PIK3CA
- PIK3CD
- ATR
- PIK3CB
Mechanisms of action (all sources)
- MTOR inhibitor
- PI3K inhibitor
- Serine/threonine-protein kinase mTOR inhibitor
- ATR inhibitor
- PIK3CA INHIBITOR
- PIK3CD INHIBITOR
- PIK3CG INHIBITOR
- MTOR MODULATOR
- PIK3CG MODULATOR
Cross-references
Synonyms
- BEZ-235
- Nvp-bez-235
- RTB101
- BEZ235
- NSC-751249
- NVP-BEZ235
- NVP-BEZ235-NX
- RTB-101
- S14-0511
- NVP-BEZ-235
- NVP-BEZ235, BEZ235
- 2-(4-(2,3-dihydro-3-methyl-2-oxo-8-(quinolin-3-yl)imidazo[4,5-c]quinolin-1-yl)phenyl)-2-methylpropanenitrile
- NVP BEZ235
- NVP BEZ 235
- BEZ 235
- NVPBEZ235
- RUJ6Z9Y0DT
- NSC 751249
- CHEBI:71952
- dactolisibum
- RefChem:585151
- DTXCID10161090
- BEZ235 (NVP-BEZ235, Dactolisib)
- MFCD10565944
- S1009
- BEZ235 (NVP-BEZ235)
- Dactolisib [USAN]
- C30H23N5O
- Dactolisib (BEZ235)
- Dactolisib [USAN:INN]
- UNII-RUJ6Z9Y0DT
- Kinome_2911
- CT-BEZ
- DACTOLISIB [INN]
- Dactolisib (USAN/INN)
- Nvp-bez235, free base
- mTOR Inhibitor, BEZ235
- DACTOLISIB [WHO-DD]
Look up DACTOLISIB in the interactive SynDRA portal →